Overview and Scope
Clinical chemistry is a quantitative field of study that measures the concentrations of biologically significant chemicals, or analytes, in bodily fluids.
Sizing and Forecast
The clinical chemistry market size has grown strongly in recent years. It will grow from <b>$14.04 billion in 2023 to $15.02 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. </b> The growth in the historic period can be attributed to increased diagnostic testing demand, healthcare industry growth, aging population, increased disease diagnosis and management, and research and development.
The clinical chemistry market size is expected to see strong growth in the next few years. It will grow to <b>$20.06 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%. </b> The growth in the forecast period can be attributed to increasing demand for precision medicine, growing need for biomarker discovery, increasing demand for personalized healthcare, emerging infectious diseases, and telemedicine and remote monitoring. Major trends in the forecast period include advanced analytical techniques, ai and machine learning integration, technological innovations, laboratory automation, and cutting-edge solutions.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/clinical-chemistry-global-market-report
Segmentation & Regional Insights
The clinical chemistry market covered in this report is segmented –
1) By Product: Analyzers, Reagents And Consumables
2) By Application: General Chemistry Test, Liver Function Test, Kidney Function Test, Urinalysis, Electrolyte Panel, Lipid Profile, Specialty Chemical Test, Other Applications
3) By End User: Hospitals, Diagnostic Or Pathology Centers, Ambulatory Surgery Centers, Other End Users
<b>North America</b> was the largest region in the chemical chemistry market in 2023. <b>Asia-Pacific</b> is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical chemistry market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7630&type=smp
Major Driver Impacting Market Growth
The increase in the prevalence of chronic diseases is expected to propel the growth of the clinical chemistry market going forward. A chronic disease is a condition that lasts for a year or longer, necessitates continuous medical care, restricts daily activities, or both. Chronic diseases, including diabetes, cancer, and heart disease, are the top causes of death and disability across the globe. Clinical chemistry creates and enhances techniques for determining the illness status and risk of a number of chronic diseases, such as cardiovascular disease, diabetes, and hormone disorders. It uses laboratory support for initiatives involving the flu and particular infectious diseases. In September 2023, the World Health Organization (WHO) reported that chronic diseases kill 41 million people each year, equivalent to 74% of all deaths globally . Therefore, the increasing prevalence of chronic diseases is driving the clinical chemistry market growth.
Key Industry Players
Major companies operating in the clinical chemistry market include <b> Abbott Laboratories, F. Hoffmann-La Roche Ltd., ELITechGroup SAS, Beckman Coulter Inc., Thermo Fisher Scientific Inc., Siemens AG, Ortho Clinical Diagnostics Holdings plc, Diatron Mi Apac Private Limited, Nova Biomedical Corporation, Johnson & Johnson Services Inc., Alfa Wassermann USA Inc., HORIBA Ltd., Mindray Medical International Limited, Randox Laboratories Limited, SYNLAB International GmbH, Agilent Technologies Inc., Alcami Corporation, ARUP Laboratories Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Charles River Laboratories International Inc., Danaher Corporation, Eurofins Scientific SE, GE Healthcare Technologies Ltd., Horiba Medical Inc., Laboratory Corporation, Luminex Corporation, Medtronic plc, PerkinElmer Inc., Quest Diagnostics Incorporated, Sysmex Corporation, Tosoh Corporation, Trinity Biotech plc, Waters Corporation, Werfen S.A. </b>
The clinical chemistry market report table of contents includes:
1. Executive Summary
2. Clinical ChemistryMarket Characteristics
3.Clinical Chemistry Market Trends And Strategies
4.Clinical Chemistry Market analysis
5.Clinical Chemistry Market Size And Growth
6.Clinical Chemistry Segmentation
7.Clinical Chemistry Regional And Country Analysis
.
.
.
27.Clinical Chemistry Competitive Landscape And Company Profiles
28.Clinical Chemistry Key Mergers And Acquisitions
29.Clinical Chemistry Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- ELITechGroup SAS
- Beckman Coulter Inc.
- Thermo Fisher Scientific Inc.
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Europe Clinical Chemistry Analyzer Market By Product (Analyzers, Reagents, Other Products), Test (Basic Metabolic Panels, Electrolyte Panels, Liver Panels, Lipid Profiles, Renal Profiles, Thyroid Function Panels, Specialty Chemical Tests), End Users (Academic Research Centers, Diagnostic Laboratories, Hospitals, Other End Users), Country (Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe) – Industry Trends and Forecast to 2026Market Analysis: Europe Clinical Chemistry Analyzer MarketEurope Clinical chemistry analyzer market is registering a substantial CAGR in the forecast period of 2019-2026.
The rise in the market can be attributed to the increase in Laboratory Automation, reagent rental agreement and rapidly increasing aging populationGet More Insights About the Europe Clinical Chemistry Analyzer Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-clinical-chemistry-analyzer-marketMarket Definition: Europe Clinical Chemistry Analyzer MarketClinical chemistry is an integral part of the body fluids evaluation and evaluation clinical pathology that plays a significant part for multifaceted disease diagnosis and therapy.
The basis of photometric examination, colorimetric testing, latex agglutination, ion-selector potentiometry are developed by the clinical chemistry analyzers in order to analyze blood, urine, serum, plasma and the other body fluids.Market DriversRapidly aging population is an important indirect driver for growth of this marketGrowing occurrence of lifestyle infections is contributing to the growth of the marketIncrease in the number of reagent rental agreements is boosting the growth of the marketIncrease in laboratory automation market is propelling the growth of the marketMarket RestraintsNecessity of high capital investments is hampering the growth of the marketHigh degree of consolidation to act as an entry barrier for new entrants is hindering the growth of the marketStringent regulatory policies for medical devices are restricting the growth of the marketKnow more about this report https://www.databridgemarketresearch.com/reports/europe-clinical-chemistry-analyzer-marketSegmentation: Europe Clinical Chemistry Analyzer MarketBy ProductAnalyzersSmall analyzersMedium analyzersLarge analyzersVery large analyzersReagentsCalibratorsControlsStandardsOther ProductsBy TestBasic Metabolic PanelsElectrolyte PanelsLiver PanelsLipid ProfilesRenal ProfilesThyroid Function PanelsSpecialty Chemical TestsBy End UsersAcademic Research CentersDiagnostic LaboratoriesHospitalsOther End UsersBy CountryGermanyItalyU.K.FranceSpainNetherlandsBelgiumSwitzerlandTurkeyRussiaRest of EuropeKey Developments in the Market:In March 2019, ViroGates A / S, which supplies blood test devices, mainly for emergency departments in clinics, announces that it has finished the creation and legislative authorization of its suPARnostic TurbiLatex item for Roche Diagnostics cobas c 502, one of the most widely used clinical chemistry components for photometric assays, such as suPAR, in big, main university labs across Europe.In September 2017, Siemens Healthineers announced the CE Mark and the worldwide business accessibility of its Atellica Solution —scalable, flexible, automation-ready immunoassay and chemical analyzers.
Atellica Solution offers laboratory diagnostics experts with command and ease so that they can devote more time managing results and less time on activities.Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=europe-clinical-chemistry-analyzer-marketCompetitive Analysis:Europe Clinical chemistry analyzer market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.
The report includes market shares of Clinical chemistry analyzer market for EuropeKey Market Competitors:Few of the major market competitors currently working in the Europe Clinical chemistry analyzer market are Abbott , Danaher., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd. , Johnson & Johnson Services, Inc., Siemens, ELI Tech Group, HORIBA, Ltd. , Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Randox Laboratories Ltd. United Kingdom, Ortho Clinical Diagnostics, Nova Biomedical , Sysmex Corporation, DiaSys Diagnostic Systems GmbH , Endress + Hauser Management AG ., Diatron , SFRI., EKF Diagnostics among others.Research Methodology: Europe Clinical Chemistry Analyzer MarketData collection and base year analysis is done using data collection modules with large sample sizes.
Also market share analysis and key trend analysis are the major success factors in the market report.
In-depth analysis of Clinical Chemistry Analyzers Market 2020The Report Titled “Clinical Chemistry Analyzers Market Report 2020, Competitive Landscape, Trends, and Opportunities” offers an in-depth assessment of the market by looking at the Market Growth, Drivers, Challenges, Opportunities, and Trends for the market to help the readers understand the overall scenario of the Clinical Chemistry Analyzers industry.
The Clinical Chemistry Analyzers Market report takes a holistic approach to the market and gives market insights, historical analysis, and verifiable projections pertaining to the market size in the forecast duration.
The estimations derived in this report are deduced by employing precise analytical tools, research methodologies, estimates, and reliable data sources.
This study assesses the current landscape of the ever-evolving business sector and the present and future effects of COVID-19 on the market.
To Get a Free PDF for Accurate Technical Insights, visit @ https://www.reportsanddata.com/sample-enquiry-form/1812The Clinical Chemistry Analyzers market intelligence study includes a separate section dedicated to crucial parameters like the pricing structure of vital feedstock and value chain analysis, along with the study of major suppliers of the raw materials.
In market segmentation by manufacturers, the report covers the following companies -Maltexo, Cargill , Crisp Malting, Grain Millers, Axereal, Malteurop, Ireks, Muntons, GrainCorp, Rahr Malting, Soufflet Group, EverGrain, Malt Products Corporation The market intelligence study outlines essential details of the market and the leading companies that hold a substantial portion of the global sector.
